Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 12, 2015Expert Review of VaccinesOpen Access

Enveloped virus-like particle platforms: vaccines of the future?

View Full Paper
Ask AI
Bookmark
Share

Authors

FPFabien PitoisetInsermTVThomas VazquezInsermBBBertrand BellierInserm

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Pitoiset et al. (2015) studied this question.

synapsesocial.com/papers/6a7c63b511fc6ad27510319ehttps://doi.org/10.1586/14760584.2015.1046440
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children2011 · 920 citations
  2. 2Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial2013 · 224 citations
  3. 3The Influence of Antigen Organization on B Cell Responsiveness1993 · 734 citations
  4. 4Virus-like particle-based vaccines against hepatitis C virus infection2013 · 32 citations
  5. 5Recombinant retrovirus‐like particle forming DNA vaccines in prime‐boost immunization and their use for hepatitis C virus vaccine development2009 · 36 citations